BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29984660)

  • 1. Lead Optimization Studies Towards Finding NS2B/NS3 Protease Targetspecific Inhibitors as Potential Anti-dengue Drug-like Compounds.
    Gurusamy M; Abdul JF
    Curr Drug Discov Technol; 2019; 16(3):307-314. PubMed ID: 29984660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors.
    Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS
    J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
    Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
    Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the inhibitory potency of anti-dengue phytocompounds against DENV-2 NS2B-NS3 protease: virtual screening, ADMET profiling and molecular dynamics simulation investigations.
    Purohit P; Barik D; Agasti S; Panda M; Meher BR
    J Biomol Struct Dyn; 2024 Apr; 42(6):2990-3009. PubMed ID: 37194462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
    Dwivedi VD; Tripathi IP; Mishra SK
    J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
    Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
    Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping.
    Deng J; Li N; Liu H; Zuo Z; Liew OW; Xu W; Chen G; Tong X; Tang W; Zhu J; Zuo J; Jiang H; Yang CG; Li J; Zhu W
    J Med Chem; 2012 Jul; 55(14):6278-93. PubMed ID: 22742496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
    Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
    BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
    Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR
    J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
    Velmurugan D; Mythily U; Rao K
    Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel thiadiazoloacrylamide analogues as inhibitors of dengue-2 virus NS2B/NS3 protease.
    Liu H; Wu R; Sun Y; Ye Y; Chen J; Luo X; Shen X; Liu H
    Bioorg Med Chem; 2014 Nov; 22(22):6344-52. PubMed ID: 25438757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection.
    Starvaggi J; Previti S; Zappalà M; Ettari R
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication.
    Pambudi S; Kawashita N; Phanthanawiboon S; Omokoko MD; Masrinoul P; Yamashita A; Limkittikul K; Yasunaga T; Takagi T; Ikuta K; Kurosu T
    Biochem Biophys Res Commun; 2013 Oct; 440(3):393-8. PubMed ID: 24070610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain.
    Shannon AE; Chappell KJ; Stoermer MJ; Chow SY; Kok WM; Fairlie DP; Young PR
    Protein Expr Purif; 2016 Mar; 119():124-9. PubMed ID: 26647367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of highly potent DENV NS2B-NS3 covalent inhibitors containing a phenoxymethylphenyl residue.
    Cheng J; Feng S; Zhang Y; Ding T; Jiang H; Zhang Z; Wang J; Wang X; Cheng M
    Biochem Biophys Res Commun; 2022 Oct; 627():214-219. PubMed ID: 36058105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
    Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
    Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-guided screening of chemical database to identify NS3-NS2B inhibitors for effective therapeutic application in dengue infection.
    Bhowmick S; Alissa SA; Wabaidur SM; Chikhale RV; Islam MA
    J Mol Recognit; 2020 Jul; 33(7):e2838. PubMed ID: 32060998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.
    Takagi Y; Matsui K; Nobori H; Maeda H; Sato A; Kurosu T; Orba Y; Sawa H; Hattori K; Higashino K; Numata Y; Yoshida Y
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3586-3590. PubMed ID: 28539222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay.
    Chu JJ; Lee RC; Ang MJ; Wang WL; Lim HA; Wee JL; Joy J; Hill J; Brian Chia CS
    Antiviral Res; 2015 Jun; 118():68-74. PubMed ID: 25823617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3 Proteases.
    Millies B; von Hammerstein F; Gellert A; Hammerschmidt S; Barthels F; Göppel U; Immerheiser M; Elgner F; Jung N; Basic M; Kersten C; Kiefer W; Bodem J; Hildt E; Windbergs M; Hellmich UA; Schirmeister T
    J Med Chem; 2019 Dec; 62(24):11359-11382. PubMed ID: 31769670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.